| Title |
Why tocilizumab could be an effective treatment for severe COVID-19?
|
|---|---|
| Published in |
Journal of Translational Medicine, April 2020
|
| DOI | 10.1186/s12967-020-02339-3 |
| Pubmed ID | |
| Authors |
Binqing Fu, Xiaoling Xu, Haiming Wei |
X Demographics
The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 13% |
| United States | 2 | 5% |
| United Kingdom | 2 | 5% |
| Japan | 1 | 3% |
| Philippines | 1 | 3% |
| Ireland | 1 | 3% |
| Mexico | 1 | 3% |
| Unknown | 26 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 29 | 74% |
| Scientists | 4 | 10% |
| Practitioners (doctors, other healthcare professionals) | 4 | 10% |
| Science communicators (journalists, bloggers, editors) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 714 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 714 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 87 | 12% |
| Researcher | 76 | 11% |
| Student > Master | 66 | 9% |
| Other | 53 | 7% |
| Student > Ph. D. Student | 40 | 6% |
| Other | 154 | 22% |
| Unknown | 238 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 192 | 27% |
| Biochemistry, Genetics and Molecular Biology | 52 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 43 | 6% |
| Immunology and Microbiology | 31 | 4% |
| Agricultural and Biological Sciences | 22 | 3% |
| Other | 101 | 14% |
| Unknown | 273 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 53. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2023.
All research outputs
#815,057
of 25,765,370 outputs
Outputs from Journal of Translational Medicine
#167
of 4,712 outputs
Outputs of similar age
#23,342
of 403,897 outputs
Outputs of similar age from Journal of Translational Medicine
#4
of 63 outputs
Altmetric has tracked 25,765,370 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,712 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 403,897 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.